Dr. Axe Wire · Labs & diagnostics · health

Liver Cell Mapping Study Finds Protein Tied to Alcohol-Related Hepatitis Deaths

A cell-by-cell map of diseased livers found a protein, SAA, that tracked with worse survival in alcohol-related hepatitis.

By Dr. Axe Editorial Team · October 29, 2026 · 1 source · Watch

Photo: Pexels

A study published October 23, 2026 in Hepatology mapped liver cells from people with severe alcohol-related hepatitis cell by cell and found that liver cells pumping out a protein called serum amyloid A, or SAA, were linked to worse survival.

Researchers performed single-cell RNA sequencing, a method that reads which genes are switched on inside individual cells, on liver biopsies from patients with alcohol-related hepatitis, people with earlier-stage alcohol-related liver disease, and healthy individuals. Sample size was not reported. The analysis identified several distinct cell populations tied to the disease, including SAA-producing liver cells, scarring-associated blood-vessel cells, scar-promoting connective tissue cells, immune cells called macrophages producing an enzyme called MMP19, activated T cells, and neutrophils carrying a receptor called FPR2. Researchers grew liver organoids, lab-grown miniature liver tissue, from biopsy samples and exposed them to a fluid designed to mimic the disease environment; the SAA-producing liver cells released SAA into that fluid. Blood SAA levels measured across patients at different disease stages showed higher circulating SAA was linked to reduced survival.

Computer modeling of cell communication predicted a strong signaling link between SAA from liver cells and the FPR2 receptor on neutrophils. The authors describe this SAA-FPR2 pathway as a potential driver of inflammation in alcohol-related hepatitis and a possible target for future therapies, drawn from their combined biopsy, organoid and blood data.

Alcohol-related hepatitis is severe and often life-threatening, and doctors have limited tools to predict survival or interrupt the inflammation driving it. Identifying a specific cell population and pathway tied to survival gives researchers a concrete lead for future diagnostic tests or treatments.

circulating SAA levels were elevated in AH and were associated with reduced survival

Study authorsHepatology, 2026

This is laboratory and biopsy-based cell-mapping work, not a treatment trial, so it cannot show whether lowering SAA or blocking FPR2 would help patients live longer. Sample size was not reported, and the organoid experiments used lab conditions rather than a living patient's full immune system.

Dr. Axe’s Take

This is the kind of foundational science I want before anyone talks about a new liver drug. Researchers mapped liver tissue cell by cell and found a specific inflammatory signal, SAA talking to neutrophils through FPR2, that tracks with survival in severe alcohol-related hepatitis. That is a genuine clue, not a treatment. If liver health concerns you, the actionable move is cutting inflammatory load directly: reduce alcohol intake, eat liver-supportive foods like beets and leafy greens, and ask your doctor about checking liver enzymes if you drink regularly. If you are diagnosed with liver disease, keep working with your doctor on treatment.

— Dr. Axe

Take the Organ Health Quiz →

Story summary

Who: Liver biopsies from patients with alcohol-related hepatitis, early-stage alcohol-related liver disease, and healthy individuals; sample size not reported.
Design: Single-cell RNA sequencing of liver biopsies, immunofluorescence validation, liver organoid exposure experiments, and blood SAA measurement across disease stages.
Dose: Not applicable; organoids were exposed to a conditioned medium designed to mimic alcohol-related hepatitis.
Primary result: A distinct population of SAA-producing liver cells was identified; these cells secreted SAA in organoid cultures after exposure to the disease-mimicking medium.
Secondary: Cell-communication modeling predicted a strong SAA-FPR2 signaling link between liver cells and neutrophils. Elevated circulating SAA was linked to reduced survival.
Funding / conflicts: Funding and conflicts not reported in the abstract.
Date: Oct 23, 2026